In a relatively short span, FreeStyle Libre has achieved global leadership among continuous glucose monitoring (CGM) systems for both Type 1 and Type 2 users.Of late, the company has been gaining ...

The Libre Rio is designed to be sold over the counter, which will reduce the cost of entry for Type 2 diabetics – and non-diabetics – using Lingo. The announcement of Rio looks like a riposte ...

Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively, in the United States this summer.

Abbott's new Libre Rio and Lingo wearable sensors are aimed at the growing health and wellness market, as well as people with Type 2 diabetes that are not taking insulin.

The Abbott Lingo and Libre Rio, two over-the-counter continuous glucose monitors, are designed to help people learn more about their glucose levels.

Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds. Zacks Equity Research . Fri, May 30 ... Abbott obtained FDA approvals for two new over-the-counter CGMs called Lingo and Libre Rio ...

Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds May 30, 2025 — 10:09 am EDT Written by Zacks Equity Research for Zacks -> ...

Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds. Zacks Equity Research . Fri, 30 May 2025, 7:09 am 5 min read. In this article: ... In 2024, Abbott obtained FDA approvals for two new ...